AI vs doctor for eye surgery and keratoconus diagnosis
Part of Eyes & vision clinical trials.
This study compares an AI system to a specialist eye doctor to see which is better at diagnosing vision problems like nearsightedness, farsightedness, astigmatism, and keratoconus. Your existing medical records will be used to see how well the AI performs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of nearsightedness, farsightedness, astigmatism, or keratoconus given by an eye doctor.
- Your eye records include vision test results, prescription details, and clear images of your cornea (the clear front part of your eye).
- You do not have other serious eye diseases like advanced glaucoma or active eye infections that might confuse the diagnosis.
- You are not currently taking part in another research study that could affect this one.
- For new patients, you must sign a consent form. For past records, permission may be waived.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new artificial intelligence system that helps eye doctors make decisions. You may qualify if you are having a routine eye exam and can get clear images of both eyes.
This trial uses artificial intelligence to analyze eye images and help doctors diagnose eye diseases. It looks at images from routine care to train and test the AI system.
This trial tests how artificial intelligence can help doctors make better decisions about eye diseases. It may be a good fit if you have an eye condition and can share your medical records and images.
This trial uses artificial intelligence to help doctors make better decisions about eye disease. It analyzes your medical records and images to see how AI can improve care and track disease.
This trial uses a smart computer system to help diagnose multiple eye diseases by looking at your eye scans. You may qualify if you have one of the listed eye conditions and your scans are clear enough for the AI to analyze.
This trial tests whether giving doctors an AI second opinion on retinal scans helps them make better treatment decisions for people with a specific eye disease called nAMD. It's a short, one-time study for eye doctors, not for patients.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.